Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sci Transl Med. 2013 Oct 23;5(208):208ra145. doi: 10.1126/scitranslmed.3006702.
Natural killer (NK) cells play critical roles in immune defense and reproduction, yet remain the most poorly understood major lymphocyte population. Because their activation is controlled by a variety of combinatorially expressed activating and inhibitory receptors, NK cell diversity and function are closely linked. To provide an unprecedented understanding of NK cell repertoire diversity, we used mass cytometry to simultaneously analyze 37 parameters, including 28 NK cell receptors, on peripheral blood NK cells from 5 sets of monozygotic twins and 12 unrelated donors of defined human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genotype. This analysis revealed a remarkable degree of NK cell diversity, with an estimated 6000 to 30,000 phenotypic populations within an individual and >100,000 phenotypes in the donor panel. Genetics largely determined inhibitory receptor expression, whereas activation receptor expression was heavily environmentally influenced. Therefore, NK cells may maintain self-tolerance through strictly regulated expression of inhibitory receptors while using adaptable expression patterns of activating and costimulatory receptors to respond to pathogens and tumors. These findings further suggest the possibility that discrete NK cell subpopulations could be harnessed for immunotherapeutic strategies in the settings of infection, reproduction, and transplantation.
自然杀伤 (NK) 细胞在免疫防御和生殖中发挥着关键作用,但仍然是人们了解最少的主要淋巴细胞群。由于其激活受多种组合表达的激活和抑制性受体控制,因此 NK 细胞的多样性和功能密切相关。为了前所未有地了解 NK 细胞库的多样性,我们使用质谱流式细胞术同时分析了来自 5 对同卵双胞胎和 12 名无关供体的外周血 NK 细胞的 37 个参数,包括 28 个 NK 细胞受体,这些供体的人类白细胞抗原 (HLA) 和杀伤细胞免疫球蛋白样受体 (KIR) 基因型是确定的。这项分析揭示了 NK 细胞多样性的显著程度,在个体内估计有 6000 到 30000 个表型群体,在供体面板中有超过 100000 个表型。遗传在很大程度上决定了抑制性受体的表达,而激活受体的表达则受到环境的强烈影响。因此,NK 细胞可能通过严格调控抑制性受体的表达来维持自身耐受,同时利用激活和共刺激受体的适应性表达模式来应对病原体和肿瘤。这些发现进一步表明,离散的 NK 细胞亚群可能被用于感染、生殖和移植背景下的免疫治疗策略。